Which treatment for nonalcoholic fatty liver disease?

被引：9
|
作者：
Moscatiello, S.
Marzocchi, R.
Villanova, N.
Bugianesi, E.
Marchesini, G. [1 ]
机构：
[1] Alma Mater Studiorum Univ Bologna, Policlin S Orsola, Unit Clin Dietet, I-40138 Bologna, Italy
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2008年 / 8卷 / 08期
关键词：
D O I：
10.2174/138955708784912193
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Subjects with nonalcoholic fatty liver disease are at risk of progressive liver failure. Lifestyle changes including weight-loss strategies and increased physical activity remain the first-line approach, but a few pharmacological treatments have also been successfully tested. Several drugs improve biochemistry, only a few improve histology; in all cases, the results were not sustained after treatment stop. Pharmacological treatment is not so far indicated outside controlled clinical trials with histological outcomes.
引用
收藏
页码：767 / 775
页数：9
相关论文
共 50 条
  • [31] Antioxidant treatment in nonalcoholic fatty liver disease Reply
    Basaranoglu, Metin
    Ormeci, Necati
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (04): : 468 - 469
  • [32] Treatment of nonalcoholic fatty liver disease: A systematic review
    Socha, P.
    Horwath, A.
    Dziechciarz, P.
    Dhawan, A.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 : 169 - 169
  • [33] Current treatment options for nonalcoholic fatty liver disease
    Shetty, Akshay
    Syn, Wing-Kin
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (03) : 168 - 176
  • [34] Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?
    Tsankof, Alexandra
    Neokosmidis, Georgios
    Koureta, Evgenia
    Veneti, Stavroula
    Cholongitas, Evangelos
    Tziomalos, Konstantinos
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [35] Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
    Golubeva, Julia A.
    Sheptulina, Anna F.
    Elkina, Anastasia Yu.
    Liusina, Ekaterina O.
    Kiselev, Anton R.
    Drapkina, Oxana M.
    [J]. BIOMEDICINES, 2023, 11 (09)
  • [36] Review of Treatment Options for Nonalcoholic Fatty Liver Disease
    Corrado, Richele L.
    Torres, Dawn M.
    Harrison, Stephen A.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2014, 98 (01) : 55 - +
  • [37] Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease
    Stephen A. Harrison
    Adrian M. Di Bisceglie
    [J]. Drugs, 2003, 63 : 2379 - 2394
  • [38] The treatment of nonalcoholic fatty liver disease with metformin and lactulose
    Meparidze, M.
    Kipshidze, N. N.
    Kodua, T.
    Jebashvili, M.
    Kakauridze, N.
    Khelashvili, M.
    Mosistrapishvili, M.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 410 - 410
  • [39] Evaluation of Statin Treatment for Nonalcoholic Fatty Liver Disease
    Newsome, Jonathan S.
    [J]. JOURNAL OF PHARMACY TECHNOLOGY, 2016, 32 (04) : 169 - 173
  • [40] The pharmacological treatment of nonalcoholic fatty liver disease in children
    Crudele, Annalisa
    Panera, Nadia
    Braghini, Maria Rita
    Balsano, Clara
    Alisi, Anna
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (11) : 1219 - 1227
12345